UPDATE 1-Teva says Actavis deal to close by April as profit falls By: Reuters: Company News February 11, 2016 at 09:39 AM EST * Sees Q1 adjusted EPS $1.32-$1.36, revenue $4.7-$4.9 bln (Adds Teva comments, details from conference call) Read More >> Related Stocks: Allergan Plc Momenta Pharma Teva Pharmaceutical Industries ADR